Daniel L. Morganstein
- Oncology top 10%
- Epidemiology top 10%
- Molecular Biology
- Physiology top 10%
- Neurology top 10%
- Co-authors
- Malcolm G. ParkerRoger WhiteMark ChristianJames LarkinPanagiotis AnagnostisAndromachi VryonidouStavroula Α. PaschouDimitrios G. Goulis
- Topics
- Cancer Immunotherapy and Biomarkers (12 papers)Neuroendocrine Tumor Research Advances (11 papers)Neuroblastoma Research and Treatments (9 papers)
- Cited by
- OncologyPhysiologyNeurology
- Journals
- Journal of Clinical OncologyMolecular and Cellular BiologyThe Journal of Clinical Endocrinology & Metabolism
- Partner nations
- United KingdomSwitzerlandIsrael
In The Last Decade
Daniel L. Morganstein
36 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 79
- Oncology 425
- Epidemiology 335
- Molecular Biology 330
- Physiology 279
- Neurology 153
Countries citing papers authored by Daniel L. Morganstein
This map shows the geographic impact of Daniel L. Morganstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Morganstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Morganstein more than expected).
Fields of papers citing papers by Daniel L. Morganstein
This network shows the impact of papers produced by Daniel L. Morganstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Morganstein. The network helps show where Daniel L. Morganstein may publish in the future.
Co-authorship network of co-authors of Daniel L. Morganstein
This figure shows the co-authorship network connecting the top 25 collaborators of Daniel L. Morganstein. A scholar is included among the top collaborators of Daniel L. Morganstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel L. Morganstein. Daniel L. Morganstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 9 | |
| 3 | 4 | |
| 4 | 4 | |
| 5 | 19 | |
| 6 | 26 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 144 | |
| 10 | 2 | |
| 11 | 145 | |
| 12 | 29 | |
| 13 | 61 | |
| 14 | Human fetal mesenchymal stem cells can differentiate into white and brown adipocytes, and reveal a role for ERR[alpaha] in human UCP1 expression | 3 |
| 15 | 29 | |
| 16 | 18 | |
| 17 | 2 | |
| 18 | 59 | |
| 19 | 85 | |
| 20 | 1 |
About Daniel L. Morganstein
Daniel L. Morganstein is a scholar working on Oncology, Neurology and Endocrinology, Diabetes and Metabolism, having authored 37 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Neuroendocrine Tumor Research Advances (11 papers) and Neuroblastoma Research and Treatments (9 papers). The work is most often cited by research in Oncology (425 citations), Physiology (279 citations) and Neurology (153 citations). Daniel L. Morganstein has collaborated with scholars based in United Kingdom, Switzerland and Israel. Frequent co-authors include Malcolm G. Parker, Roger White, Mark Christian, James Larkin, Panagiotis Anagnostis, Andromachi Vryonidou, Stavroula Α. Paschou, Dimitrios G. Goulis, Anastasia Dede and Birger Herzog. Their work appears in journals such as Journal of Clinical Oncology, Molecular and Cellular Biology and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.